Aligos Therapeutics, Inc.: Form 8-K, filed Sep 15, 2026
Filed with the SEC on Sep 15, 2026 and accepted by EDGAR at Sep 15, 2026, 16:03 ET.
Items reported
- Item 1.01 Entry into a material agreement
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001193125-26-391880. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.